Transparency Guidelines on Relation with Medical Institutions
February 1, 2020

(Revised January 1, 2024)
TAUNS Laboratories, Inc.

Basic Policy
TAUNS Laboratories, Inc. (hereinafter referred to as "the Company") establishes the "Transparency

Guidelines on Relation with Medical Institutions" with reference to the "Transparency Guidelines for
the Relation between Corporate Activities and Medical Institutions" of the Japan Association ofClinical Reagents Industries and defines it as our code of conduct. The purpose of these Guidelines isto gain a broad understanding that our corporate activities contribute to the development of lifesciences, including medical care, and are conducted with high ethical standards.

Disclosure of Funding Provided to Medical Institutions
1. Method of Disclosure

The information is disclosed at the website of TAUNS Laboratories, Inc. (https://www.tauns.co.jp/en).

2. Timing of Disclosure

The information will be disclosed for one year after the publication of the financial statements for theprevious fiscal year. However, for "B. Academic Research Support Expenses" subject to disclosure,"expenses for co-sponsoring seminars and other events related to holding meetings" will be disclosed
until payment in FY2023, and "expenses for co-sponsoring seminars and other events related toholding meetings, advertising fees, exhibition fees, etc." will be disclosed from payment in FY2024.

3. Scope of Disclosure

The scope of information to be disclosed with regard to funding to medical institutions is as follows:A) Research and Development Expenses

Research and development expenses include expenses for clinical performance testing and evaluation,
as well as expenses for side effect reporting and various post-marketing studies conducted incompliance with government regulations, such as the GVP Ordinance.
Joint research expenses

Name of the institution to be provided (*1), Annual number ofCommissioned research

Name of the institution to be provided (*1), Annual number of

Other expenses related toAnnual total amount

expenses

research and development

cases/total amountcases/total amount(*1) Name of the institution to be provided: Based on the content of the contract, "Name of the institution", "Name of theorganization within the institution", if the contract is signed with an individual, "Affiliation/Title/Name of an individual" shall bepublished.

B) Academic Research Support Expenses

Scholarship donations and general donations to promote academic research or research support, aswell as donations to academic conferences and expenses for co-sponsoring conferences with academicsocieties to support conferences.

The " Expenses for co-sponsoring academic conferences” includes expenses for co-sponsoring
seminars, advertising fees, exhibition fees, etc., incidental to the holding of the meeting.
Scholarship donation

XX University XX Course: Number of donations, XX yen

General donation

XX University (XX Foundation): Number of donations, XX yen

Donation to academic

XXth XX Academic Conference (XX Regional Meeting, XX Study

Expenses for co-sponsoring

XXth XX Academic Conference (XX Regional Meeting, XX Study

conferences, etc.
conference, etc.

Group Meeting): XX yen
Group Meeting): XX yenC) Manuscript/Writing Fees, etc.

Payment for lectures, writing manuscripts, consulting services, etc., to provide scientific information
on medical and pharmaceutical sciences, including the Company's products.
Lecture fees

Professor (Director) XX, XX Department of XX University (XXManuscript writing

Professor (Director) XX, XX Department of XX University (XXConsulting and other

Professor (Director) XX, XX Department of XX University (XXfee/supervision fees
outsourcing fees

Hospital): Number of services, XX yen
Hospital): Number of services, XX yen
Hospital): Number of services, XX yenD) Information Provision Related Expenses

Expenses for lectures and informational meetings to provide information on the Company's products
and medical/pharmaceutical sciences to healthcare professionals.
Expenses for meetings including

Annual number of meetings and total amountInformational meeting expenses

Annual number of meetings and total amount

Expenses for providing medical andAnnual total amountlectures, etc.

pharmaceutical literatureE) Other Expenses

Expenses for hospitality as social courtesy
Expenses for hospitality, etc.

Annual total amount